MX9303572A - Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene. - Google Patents
Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene.Info
- Publication number
- MX9303572A MX9303572A MX9303572A MX9303572A MX9303572A MX 9303572 A MX9303572 A MX 9303572A MX 9303572 A MX9303572 A MX 9303572A MX 9303572 A MX9303572 A MX 9303572A MX 9303572 A MX9303572 A MX 9303572A
- Authority
- MX
- Mexico
- Prior art keywords
- protease inhibitors
- procedure
- preparation
- pharmaceutical formulation
- human immunodeficiency
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 208000033065 inborn errors of immunity Diseases 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000004030 hiv protease inhibitor Substances 0.000 abstract 1
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01G—PRELIMINARY TREATMENT OF FIBRES, e.g. FOR SPINNING
- D01G1/00—Severing continuous filaments or long fibres, e.g. stapling
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- D—TEXTILES; PAPER
- D02—YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
- D02G—CRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
- D02G3/00—Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
- D02G3/02—Yarns or threads characterised by the material or by the materials from which they are made
-
- D—TEXTILES; PAPER
- D02—YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
- D02J—FINISHING OR DRESSING OF FILAMENTS, YARNS, THREADS, CORDS, ROPES OR THE LIKE
- D02J1/00—Modifying the structure or properties resulting from a particular structure; Modifying, retaining, or restoring the physical form or cross-sectional shape, e.g. by use of dies or squeeze rollers
- D02J1/22—Stretching or tensioning, shrinking or relaxing, e.g. by use of overfeed and underfeed apparatus, or preventing stretch
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/402—Amides imides, sulfamic acids
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M7/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made of other substances with subsequent freeing of the treated goods from the treating medium, e.g. swelling, e.g. polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
- D06M2200/40—Reduced friction resistance, lubricant properties; Sizing compositions
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/02—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Mechanical Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención proporciona nuevos inhibidores de proteasa del HIV, formulaciones farmacéuticas que contienen estos compuestos y método para su uso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90144792A | 1992-06-19 | 1992-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9303572A true MX9303572A (es) | 1994-01-31 |
Family
ID=25414213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9303572A MX9303572A (es) | 1992-06-19 | 1993-06-15 | Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene. |
Country Status (21)
Country | Link |
---|---|
US (1) | US5578608A (es) |
EP (1) | EP0575097B1 (es) |
JP (1) | JP3195462B2 (es) |
KR (2) | KR940005620A (es) |
CN (1) | CN1082035A (es) |
AU (1) | AU663958B2 (es) |
BR (1) | BR9302389A (es) |
CA (1) | CA2098165A1 (es) |
CO (1) | CO4130200A1 (es) |
CZ (1) | CZ113393A3 (es) |
DE (1) | DE69329606T2 (es) |
ES (1) | ES2152241T3 (es) |
FI (1) | FI932847A (es) |
HU (1) | HUT67571A (es) |
IL (1) | IL105973A0 (es) |
MX (1) | MX9303572A (es) |
NO (1) | NO932130L (es) |
NZ (1) | NZ247837A (es) |
PL (1) | PL299369A1 (es) |
TW (1) | TW218873B (es) |
YU (1) | YU42893A (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9306058A (pt) | 1992-03-11 | 1997-11-18 | Narhex Ltd | Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos |
US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
MXPA93002392A (es) | 1992-03-11 | 2005-02-04 | Narhex Ltd | Derivados amino de hidrocarburos-oxo e hidroxi-substituidos. |
ZA945719B (en) * | 1993-08-09 | 1996-02-01 | Lilly Co Eli | Identification and use of protease inhibitors |
EP0812839A1 (en) * | 1994-12-08 | 1997-12-17 | LG Chemical Limited | Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof |
US5696134A (en) * | 1993-11-30 | 1997-12-09 | Lg Chemical Limited | Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof |
KR0125117B1 (ko) * | 1994-06-15 | 1997-12-05 | 성재갑 | 항 에이즈(aids)효과를 갖는 신규한 인간 면역 결핍 바이러스(hiv)프로테아제 억제 화합물 및 그의 제조방법 |
KR0159652B1 (ko) * | 1995-10-26 | 1998-12-01 | 성재갑 | 항 에이즈 효과를 갖는 비가역적 인간 면역 결핍 바이러스 프로테아제 저해제 및 그의 제조방법 |
US5693847A (en) * | 1995-04-19 | 1997-12-02 | Vertex Pharmaceuticals Incorporated | Heteroatom functionalized α-methyl ketones |
US7431956B2 (en) | 2003-06-20 | 2008-10-07 | Sensient Imaging Technologies, Inc. | Food grade colored fluids for printing on edible substrates |
BRPI0511926B1 (pt) | 2004-06-10 | 2014-08-12 | Sensient Imaging Technologies | Fluido colorido de grau alimentício, processo de aplicação de um colorante comestível a uma superfície de um substrato comestível e substrato comestível |
US9113647B2 (en) | 2008-08-29 | 2015-08-25 | Sensient Colors Llc | Flavored and edible colored waxes and methods for precision deposition on edible substrates |
WO2014075676A1 (en) * | 2012-11-15 | 2014-05-22 | V-Biotek Holding Aps | Amines from trigonella foemum - graecum |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
JPS60193979A (ja) * | 1984-03-15 | 1985-10-02 | Mitsui Toatsu Chem Inc | Ν−(ω−グリシドキシアルキル)置換アミド化合物及びその製造方法 |
US5155227A (en) * | 1984-07-19 | 1992-10-13 | University Of Florida | Compounds for site-enhanced delivery of radionuclides |
FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
AU8320691A (en) * | 1990-07-06 | 1992-02-04 | Smithkline Beecham Corporation | Inhibitors of retroviral proteases |
IE913840A1 (en) * | 1990-11-20 | 1992-05-20 | Abbott Lab | Retroviral protease inhibiting compounds |
CN1071930A (zh) * | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
-
1993
- 1993-06-10 EP EP93304504A patent/EP0575097B1/en not_active Expired - Lifetime
- 1993-06-10 CA CA002098165A patent/CA2098165A1/en not_active Abandoned
- 1993-06-10 NO NO932130A patent/NO932130L/no unknown
- 1993-06-10 IL IL105973A patent/IL105973A0/xx unknown
- 1993-06-10 ES ES93304504T patent/ES2152241T3/es not_active Expired - Lifetime
- 1993-06-10 TW TW082104596A patent/TW218873B/zh active
- 1993-06-10 NZ NZ247837A patent/NZ247837A/en unknown
- 1993-06-10 DE DE69329606T patent/DE69329606T2/de not_active Expired - Fee Related
- 1993-06-10 CZ CZ931133A patent/CZ113393A3/cs unknown
- 1993-06-15 MX MX9303572A patent/MX9303572A/es unknown
- 1993-06-17 PL PL29936993A patent/PL299369A1/xx unknown
- 1993-06-17 BR BR9302389A patent/BR9302389A/pt not_active Application Discontinuation
- 1993-06-17 JP JP14606193A patent/JP3195462B2/ja not_active Expired - Fee Related
- 1993-06-18 CO CO93392259A patent/CO4130200A1/es unknown
- 1993-06-18 KR KR1019930011214A patent/KR940005620A/ko not_active Application Discontinuation
- 1993-06-18 FI FI932847A patent/FI932847A/fi not_active Application Discontinuation
- 1993-06-18 HU HU9301795A patent/HUT67571A/hu unknown
- 1993-06-18 KR KR1019930011216A patent/KR940000634A/ko not_active Application Discontinuation
- 1993-06-18 AU AU41354/93A patent/AU663958B2/en not_active Ceased
- 1993-06-19 CN CN93107424A patent/CN1082035A/zh active Pending
- 1993-06-21 YU YU42893A patent/YU42893A/sh unknown
-
1995
- 1995-01-17 US US08/372,722 patent/US5578608A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL299369A1 (en) | 1993-12-27 |
DE69329606T2 (de) | 2001-05-03 |
CN1082035A (zh) | 1994-02-16 |
CA2098165A1 (en) | 1993-12-20 |
NO932130L (no) | 1993-12-20 |
KR940005620A (ko) | 1994-03-21 |
JP3195462B2 (ja) | 2001-08-06 |
CO4130200A1 (es) | 1995-02-13 |
HUT67571A (en) | 1995-04-28 |
NZ247837A (en) | 1995-04-27 |
FI932847A (fi) | 1993-12-20 |
ES2152241T3 (es) | 2001-02-01 |
CZ113393A3 (en) | 1994-03-16 |
KR940000634A (ko) | 1994-01-03 |
BR9302389A (pt) | 1994-01-11 |
AU663958B2 (en) | 1995-10-26 |
FI932847A0 (fi) | 1993-06-18 |
YU42893A (sh) | 1996-07-24 |
JPH0656812A (ja) | 1994-03-01 |
EP0575097B1 (en) | 2000-11-02 |
AU4135493A (en) | 1993-12-23 |
US5578608A (en) | 1996-11-26 |
TW218873B (es) | 1994-01-11 |
EP0575097A1 (en) | 1993-12-22 |
IL105973A0 (en) | 1993-10-20 |
NO932130D0 (no) | 1993-06-10 |
HU9301795D0 (en) | 1993-09-28 |
DE69329606D1 (de) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR011069A1 (es) | Compuestos amidino, proceso para su preparacion, compuestos intermediarios, formulaciones farmaceuticas que los comprenden, y su uso en la fabricacion de un medicamento como inhibidor de la oxido nitrico sintasa inducible. | |
ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9202289A (es) | Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9305769A (es) | Nuevos derivados de analogos del taxol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9207382A (es) | Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene. | |
ES2095432T3 (es) | Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
MX9200180A (es) | DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE. | |
ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9205280A (es) | Derivados de benzanilida, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9204354A (es) | Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen. | |
MX9203972A (es) | Compuestos inhibidores de la proteasa codificada por el virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulado farmaceutico que los contiene. | |
MX9102501A (es) | Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion. | |
MX9204140A (es) | Nuevos derivados de analogos de taxol, procedimiento para su preparacion y composicion farmaceutica que los contienen. | |
MX9301296A (es) | Nuevos compuestos de diarilsulfonamidas, procedimiento para su preparacion y formulado farmaceutico que los comprende. | |
MX9303572A (es) | Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene. | |
ES2126766T3 (es) | 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo. | |
ES2018478B3 (es) | Un sistema para preparar una composicion desensibilizante dental. | |
MX9204844A (es) | Derivados de benzodioxano, procedimiento para su preparacion composiciones farmaceuticas que los contienen. | |
MX9308005A (es) | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. | |
ES2178055T3 (es) | Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9304793A (es) | Glicanas de actividad inmunoestimulante. | |
MX9201642A (es) | Derivados de amidino fenil alanina, procedimiento para su preparacion, su empleo y agentes que los contienen. | |
MX9308025A (es) | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. |